Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

277
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
277
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

193
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
193
Tissue Transplantation01:24

Tissue Transplantation

366
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
366

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preparing Emergency Medical Services for Prehospital Buprenorphine: Examining a Train-the-Trainer Approach to Strengthening the Overdose Chain of Survival.

Journal of the American College of Emergency Physicians open·2026
Same author

Validation of self‑harm prediction models among formerly incarcerated individuals using health data.

Health & justice·2026
Same author

Stimulant Use After Loss of Access to Prescribed Opioids for Chronic Noncancer Pain.

American journal of preventive medicine·2026
Same author

Short-Acting Opioid Dose and Patient-Directed Discharge in Hospitalized Patients With Opioid Use Disorder.

JAMA network open·2026
Same author

Implementation and sustainability of hospital-based harm reduction delivery: a qualitative analysis.

Harm reduction journal·2026
Same author

Qualitative study of bubble pack use during buprenorphine low dose initiation.

Journal of the American Pharmacists Association : JAPhA·2026

Related Experiment Video

Updated: Jul 1, 2025

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
06:09

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates

Published on: May 30, 2025

116

Cannabis donation as a harm reduction strategy: a case study.

Sarah E Duhart Clarke1, Grant Victor2, Pamela Lynch3

  • 1RTI International, 3040 Cornwallis Road, 27709, Research Triangle Park, NC, USA. sduhartclarke@rti.org.

Harm Reduction Journal
|March 6, 2024
PubMed
Summary

Cannabis donation programs can be a feasible harm reduction strategy in the US, offering an adjunctive approach to mitigate harms from more dangerous substances. This case study explores the logistics and potential benefits of such a program in rural Michigan.

Keywords:
CannabisHarm reductionOverdose preventionPublic health

More Related Videos

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

192
Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies
05:25

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies

Published on: December 29, 2021

2.5K

Related Experiment Videos

Last Updated: Jul 1, 2025

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
06:09

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates

Published on: May 30, 2025

116
Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

192
Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies
05:25

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies

Published on: December 29, 2021

2.5K

Area of Science:

  • Public Health
  • Substance Use Disorders
  • Harm Reduction

Background:

  • The US faces high overdose mortality rates, necessitating effective harm reduction strategies.
  • Cannabis donation via harm reduction agencies is explored as a method to mitigate harms from more dangerous drugs, based on Canadian research.
  • This case study examines a cannabis donation program within a rural Michigan harm reduction setting.

Purpose of the Study:

  • To describe the operational logistics, feasibility, and potential benefits of a cannabis donation program.
  • To gather insights from harm reduction staff on the implementation and evolution of cannabis donation efforts.
  • To analyze administrative data comparing cannabis sales and donations.

Main Methods:

  • A community-driven research approach was used, involving harm reduction program staff interviews.
  • Administrative data from a commercial cannabis company over 20 months (September 2021-May 2023) were analyzed.
  • Ten clients received cannabis donations, with clinical staff assessing appropriateness and facilitating distribution.

Main Results:

  • Edible, oil, and topical cannabis products were predominant in donations, unlike sales which favored flower.
  • Donations constituted only 1% of total gross sales for the participating cannabis company.
  • The program provided cannabis to ten clients, with clinical staff managing distribution.

Conclusions:

  • Cannabis donation shows potential as a harm reduction strategy in the US, but sustainability depends on state laws.
  • This is the first US case study documenting cannabis donation as a harm reduction practice.
  • Further research is required to understand individual outcomes, public health impacts, legal aspects, and best practices.